New diabetes clinical trial: A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes

Published on: May 10, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Insulin 287;   Drug: Insulin glargine
Sponsor:   Novo Nordisk A/S
Not yet recruiting